Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)
1 clinical trials · Condition
◉ Watch Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)
| Record | Firm | Date |
|---|---|---|
| Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors (NCT06535607) | AstraZeneca | 2024-08-22 |
Track Sub-study 1 Cervical Cancer (Volrustomig Monotherapy) automatically
Every clearance here is in the API, with alerts when new ones post.